静脉曲张治疗市场规模、份额、成长分析（按类型、产品、最终用途和地区）- 产业预测（2025 年至 2032 年）

2022 年全球静脉曲张治疗市场价值为 13 亿美元，预计将从 2023 年的 13.9 亿美元增长到 2031 年的 23.3 亿美元，预测期内（2024-2031 年）的复合年增长率为 6.7%。

全球静脉曲张治疗市场正经历强劲成长，因为这种常见疾病的盛行率不断上升，而人口老化、久坐不动的生活方式、肥胖和遗传等因素都对这种疾病产生了影响。各种治疗方法满足了对有效治疗方案的需求，尤其是静脉内雷射消融、硬化疗法和射频消融等微创手术，这些疗法具有减轻疼痛、加速恢復时间和减少疤痕等好处。技术进步提高了治疗效果和患者满意度，超音波导引泡沫硬化疗法等创新技术越来越受欢迎。然而，挑战依然存在，包括报销问题和高昂的治疗费用，这些可能会限制治疗的可近性。此外，竞争格局正在加剧，需要在适应监管环境的同时不断进行研发。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2023年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

全球静脉曲张治疗市场规模（按类型和复合年增长率）（2024-2031）

• 市场概览
• 静脉消融
  • 静脉雷射治疗
  • 射频消融术
• 注射硬化疗法
• 手术结扎和剥离

全球静脉曲张治疗市场规模（依产品及复合年增长率）（2024 年至 2031 年）

• 市场概览
• 消融设备
• 射频消融术装置
• 雷射消熔装置
• 静脉缝合产品

全球静脉曲张治疗市场规模（依最终用途及复合年增长率） （2024-2031 年）

• 市场概览
• 医院
• 门诊手术中心
• 专科诊所

静脉曲张治疗的全球市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 按部门分類的公司份额分析
  • 收益年比比较（2021-2023年）

主要企业简介

• Medtronic plc（Ireland）
• AngioDynamics, Inc.（USA）
• Teleflex Incorporated（USA）
• Boston Scientific Corporation（USA）
• Lumenis Ltd.（Israel）
• Quanta System SpA（Italy）
• Biolitec AG（Austria）
• Dornier MedTech GmbH（Germany）
• Sciton, Inc.（USA）
• Fotona doo（Slovenia）
• Viatris Inc.（USA）
• Merz Aesthetics（USA）
• SIGVARIS Group（Switzerland）
• Essity Aktiebolag（publ）（Sweden）
• F Care Systems NV（Belgium）
• VVT Medical（Israel）
• Alma Lasers（Israel）
• Energist Group（UK）.
• Eufoton srl（Italy）
• WONTECH Co., Ltd.（South Korea）

结论和建议

Global Varicose Veins Treatment Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.39 billion in 2023 to USD 2.33 billion by 2031, growing at a CAGR of 6.7% during the forecast period (2024-2031).

The global varicose veins treatment market is experiencing robust growth, driven by the increasing prevalence of this common condition influenced by factors such as aging populations, sedentary lifestyles, obesity, and genetics. The demand for effective treatment options is being met by a range of modalities, particularly minimally invasive procedures like endovenous laser ablation, sclerotherapy, and radiofrequency ablation, which offer benefits like reduced pain, shorter recovery times, and less scarring. Technological advancements enhance treatment effectiveness and patient satisfaction, with innovative techniques such as ultrasound-guided foam sclerotherapy gaining traction. However, challenges remain, including reimbursement issues and high treatment costs, which may limit accessibility. Additionally, the competitive landscape is intensifying, necessitating ongoing research and development while navigating regulatory hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Varicose Veins Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Varicose Veins Treatment Market Segments Analysis

Global Varicose Veins Treatment Market is segmented by type, products, end use and region. Based on type, the market is segmented into endovenous ablation, injection sclerotherapy and surgical ligation & stripping. Based on products, the market is segmented into ablation devices, radiofrequency ablation devices, laser ablation devices and venous closure products. Based on end use, the market is segmented into hospitals, ambulatory surgical centers and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Varicose Veins Treatment Market

The expansion of the Global Varicose Veins Treatment market can be attributed to the heightened awareness and education surrounding varicose veins and the diverse treatment options available. Various public awareness campaigns, coupled with patient education initiatives and the dissemination of information through multiple platforms, have played a pivotal role in motivating individuals experiencing varicose veins to pursue suitable treatment solutions. This increased understanding of the condition has helped to eliminate stigma and misinformation, ultimately fostering a more proactive approach among patients in seeking effective care and management for their venous health issues.

Restraints in the Global Varicose Veins Treatment Market

The global varicose veins treatment market faces significant challenges due to regulatory requirements and the product approval processes that manufacturers must navigate. These stringent regulations can vary widely across different countries, creating a complex landscape that demands time and financial resources. As a result, obtaining the necessary approvals can delay the launch of new treatments and innovations, ultimately impacting the market's growth and the availability of advanced therapeutic options for patients. This regulatory burden can hinder manufacturers' ability to adapt and respond to emerging trends and advancements in varicose vein treatment strategies.

Market Trends of the Global Varicose Veins Treatment Market

The Global Varicose Veins Treatment market is increasingly witnessing a trend towards combination therapies as healthcare providers seek to enhance treatment efficacy and patient satisfaction. By integrating multiple modalities, such as endovenous ablation with sclerotherapy, practitioners can effectively address various facets of venous disease, improving overall outcomes. This approach acknowledges the complexities of varicose veins, leading to more tailored treatment plans and fostering patient confidence in their care. As awareness of varicose vein complications grows and patients demand more personalized treatment options, the market is expected to expand, driving innovation and collaborations among leading medical technology companies and healthcare providers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Varicose Veins Treatment Market Size by Type & CAGR (2024-2031)

• Market Overview
• Endovenous Ablation
  • Endovenous Laser Therapy
  • Radiofrequency Ablation
• Injection Sclerotherapy
• Surgical Ligation & Stripping

Global Varicose Veins Treatment Market Size by Products & CAGR (2024-2031)

• Market Overview
• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products

Global Varicose Veins Treatment Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Varicose Veins Treatment Market Size & CAGR (2024-2031)

• North America (Type, Products, End Use)
  • US
  • Canada
• Europe (Type, Products, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Products, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Products, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Products, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumenis Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta System S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolitec AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sciton, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fotona d.o.o. (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Aesthetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGVARIS Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Essity Aktiebolag (publ) (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F Care Systems NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VVT Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alma Lasers (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Energist Group (UK).
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eufoton s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations